MacroGenics, Inc.
MGNX
$1.31
-$0.06-4.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.81M | -66.97M | -97.62M | -136.37M | -23.24M |
| Total Depreciation and Amortization | 7.47M | 7.54M | 7.39M | 7.50M | 8.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.59M | -10.34M | 20.75M | -31.40M | -133.22M |
| Change in Net Operating Assets | -10.69M | 1.39M | 11.48M | 6.86M | 36.94M |
| Cash from Operations | -69.62M | -68.37M | -58.00M | -153.41M | -111.02M |
| Capital Expenditure | -2.78M | -3.71M | -3.71M | -3.61M | -2.86M |
| Sale of Property, Plant, and Equipment | 160.00K | 160.00K | 160.00K | 90.00K | 64.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 137.02M | 152.84M | 150.20M | 81.05M | -80.59M |
| Cash from Investing | 134.41M | 149.30M | 146.65M | 77.53M | -83.39M |
| Total Debt Issued | -- | -- | -- | -- | -99.66M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 796.00K | 3.44M | 3.55M | 3.60M | 3.19M |
| Repurchase of Common Stock | -366.00K | -2.48M | -2.47M | -2.54M | -2.54M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1.00K | 50.00M | 149.50M |
| Cash from Financing | 430.00K | 960.00K | 1.08M | 51.06M | 50.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.22M | 81.88M | 89.73M | -24.83M | -143.91M |